The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

A recent study has shown that YK11, a selective androgen receptor myostatin inhibitor, accelerates the expression of Follistatin in mice.

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by purerawz.mark, 2023-02-24 05:21:18

yk11 from purerawz

A recent study has shown that YK11, a selective androgen receptor myostatin inhibitor, accelerates the expression of Follistatin in mice.

Keywords: yk11,sarms

yk-11 (Myostine)


Buy YK-11 for Sale (Myostine) – Product Details A recent study has shown that YK11, a selective androgen receptor myostatin inhibitor, accelerates the expression of Follistatin in mice. Follistatin is a myostatin and activin-binding protein naturally found in the human body and has been used as a treatment for several degenerative muscle diseases. When follistatin levels are raised, myostatin levels will be inhibited. Inhibition of myostatin results in increased muscle mass and improved strength. This study revealed that mice with low levels of myostatin have twice the amount of muscle mass compared to mice with high levels of myostatin. This shows the massive potential research implications of the strong anabolic effects that YK-11 can possess


How does YK11 Work? YK11 primarily works by inhibiting myostatin. Myostatin is a protein naturally produced by muscle cells in the human body. This protein plays a crucial role in muscle movement and impedes muscle growth and strength, ensuring that muscles do not get too large as to inhibit their movement. A cell study has found that YK11 inhibits myostatin by raising the levels of follistatin. Follistatin is another naturally occurring protein in the human body. Its elevated levels have been proven to keep myostatin levels in check, helping muscles grow and strengthen.


Is YK11 A SARM? YK11 is a selective androgen receptor modulator, but it is also something more. This research compound acts similarly to SARMs in that it binds androgen receptors in the muscle and bone tissue. However, unlike SARMs, it also inhibits myostatin, the naturally occurring protein that impedes muscle growth. Furthermore, while the majority of SARMs are full agonists of androgen receptors, YK11 has been found to be a partial agonist. Yet another difference between YK11 and SARMs is that it is a steroidal compound, whereas most SARMs tend to be non-steroidal.


Click to View FlipBook Version